The US Food and Drug Administration (FDA) is committed to helping facilitate American patients’ access to lower-cost generic medicines by taking steps to enhance and streamline the development and ...

The US FDA Commissioner Scott Gottlieb announced new steps aimed at speeding up the process of reviewing generic drug marketing application and boosting competition. In a statement, the FDA regulator ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

The Generic Drugs Market has emerged as one of the most critical segments of the global pharmaceutical industry due to its ability to provide affordable and effective alternatives to branded ...

(MENAFN- GlobeNewsWire - Nasdaq) The global generic drug CRO market size was valued at USD 8.45 billion in 2024 and is predicted to hit around USD 11.73 billion by 2034, rising at a 3.36% CAGR, a ...